RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding.
Journal article
Mitsi E. et al, (2024), Cell Host Microbe
Pneumococcal carriage and disease in adults in England 2011-2019: the importance of adults as a reservoir for pneumococcus in communities.
Journal article
El Safadi D. et al, (2024), J Infect Dis
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adults.
Journal article
Urban BC. et al, (2024), Mucosal Immunol
Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients
Preprint
Gonçalves ANA. et al, (2024)
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.
Journal article
Drury RE. et al, (2024), Nat Commun, 15
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3).
Journal article
Hazenberg P. et al, (2024), BMJ Open, 14
Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population
Journal article
Doherty K. et al, (2024), Wellcome Open Research, 9, 2 - 2
Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity.
Journal article
Hoving D. et al, (2023), Commun Biol, 6
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Journal article
Mitsi E. et al, (2023), Nat Commun, 14
Assessing the use of minimally invasive self-sampling at home for long-term monitoring of the microbiota within UK families.
Journal article
Nikolaou E. et al, (2023), Sci Rep, 13
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study.
Journal article
Dula D. et al, (2023), Lancet Microbe, 4, e683 - e691
A Randomised Controlled Trial of Nasal Immunisation with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection Challenge.
Journal article
Hill H. et al, (2023), Am J Respir Crit Care Med
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Journal article
Shaw RH. et al, (2023), J Infect, 86, 574 - 583
Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshire and Bristol, UK.
Journal article
Fyles F. et al, (2023), BMJ Open Respir Res, 10
Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Preprint
Mitsi E. et al, (2023)
Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Preprint
Mitsi E. et al, (2023)
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts
Journal article
Gonzalez Dias Carvalho PC. et al, (2023), Frontiers in Immunology, 14